643067-83-8

Basic information

• Product Name: 8-BroMo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine
• Synonyms: 8-BroMo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine;1,4-Dioxino[2,3-b]pyridine, 8-bromo-2,3-dihydro-
• CAS NO: 643067-83-8
• Molecular Formula: C7H6BrNO2
• Molecular Weight: 216.03204
• Mol File: 643067-83-8.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 8-BroMo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 8-BroMo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine(643067-83-8)
• EPA Substance Registry System: 8-BroMo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine(643067-83-8)

Safety Data

• Hazardous Substances Data: 643067-83-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
8-Brom-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine is used as a precursor in the synthesis of various organic compounds for pharmaceutical applications. Its unique structure allows it to be a key component in the development of new drugs and therapeutic agents.
Used in Agricultural Industry:
BDPP is also used as an intermediate in chemical reactions for the production of materials used in agricultural applications. Its potential role in the synthesis of agrochemicals and other related products makes it a valuable compound in this industry.
Used in Research and Development:
8-Brom-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine is used in research and development for its potential biological activity and interaction with various biological systems. Further studies are needed to fully understand its potential uses and effects, which could lead to new discoveries and applications in both pharmaceutical and agricultural fields.

Upstream product

• 129421-32-5 2,3-dihydro-1,4-dioxino<2,3-b>pyridine 

Downstream Products

• 1229624-31-0 C₁₉H₂₇N₃O₆ 

Relevant articles and documents

MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS

The invention provides compounds of formula (I) or pharmaceutically acceptable salt thereof wherein ring A represents group A-I, A-II or A-III. Al represents -C(R4a)(R4a)-, -C(R4a)= -N(R4b)-, -N= -O- or -S-; A2 represents -C(R4c)(R4c)-, -C(R4c)= or -0-; A3 represents -C(R4c)(R4c)-, -C(R4c)= or -0-; A4 represents -C(R4a)(R4a)-, -C(R4a)= -N= -O- or -S-; A5 represents -C(R4a)(R4a)-, -C(R4a)= -N(R4b)-, -N= -O- or -S-; A6 represents -C(R4c)(R4c)- or -C(R4c)=; A7 represents -C(R4a)(R4a)-, -C(R4a)= -N= -O- or -S-; A8 represents -C(R4a)(R4a)-, -N(R4b)-, -O- or -S-; A9 represents -C(R4c)(R4c)- or -0-; A10 represents -C(R4c)(R4c)- or -0-; A11 represents -C(R4c)(R4c)- or -0-; A12 represents -C(R4a)(R4a)-, -O- or -S-; wherein group A-I, group A-II and group A-III de not contain adjacent oxygen atoms, adjacent oxygen and sulfur atoms or adjacent oxygen and nitrogen atoms or a moiety selected from the group consisting of N-C-N, N-C-S, S-C-S, O-C-N, O-C-O and O-C-S, wherein in each case the carbon atom in the N-C-N, N-C-S, S-C-S, O-C-N, O-C-O and O-C-S moiety is saturated; B1, B2, B3 and B4 represent independently C(R3) or N, wherein no more than two of B1, B2, B3 and B4 represent N; n is 1 or 2; and R1, R2, R3, R4a, R4b and R4c are as defined in the claims, as well as methods of using the compounds to treat proliferation diseases, in particular cancer.

ANTIBACTERIAL COMPOUNDS

Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man